Grade 3b Follicular Lymphoma
13 clinical trials · Condition
◉ Watch Grade 3b Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma (NCT04799275) | National Cancer Institute (NCI) | 2021-05-20 |
| Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma (NCT04156828) | University of Washington | 2020-03-31 |
| Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. (NCT03150329) | City of Hope Medical Center | 2017-07-18 |
| An Italian Experience on Grade 3b Follicular Lymphoma (NCT02927717) | A.O.U. Città della Salute e della Scienza | 2016-10-01 |
| Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma (NCT02541565) | University of Washington | 2015-11-24 |
| Expanded Access Program for Epcoritamab (NCT05733650) | Genmab |
Track Grade 3b Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.